We've found
3,204
archived clinical trials in
Healthy Studies
We've found
3,204
archived clinical trials in
Healthy Studies
A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model
Updated: 7/6/2015
A Phase 1, Randomized, Double Blind, Placebo Controlled, Multiple Dose, 2 Way Crossover Study To Evaluate The Safety And Pharmacodynamic Effects Of Pf 06282999 Using An Endotoxin (Lipopolysaccharide) Induced Inflammatory Response Model In Healthy Adult Subjects
Status: Enrolling
Updated: 7/6/2015
A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model
Updated: 7/6/2015
A Phase 1, Randomized, Double Blind, Placebo Controlled, Multiple Dose, 2 Way Crossover Study To Evaluate The Safety And Pharmacodynamic Effects Of Pf 06282999 Using An Endotoxin (Lipopolysaccharide) Induced Inflammatory Response Model In Healthy Adult Subjects
Status: Enrolling
Updated: 7/6/2015
Click here to add this to my saved trials
MLN3126 Single Rising Dose Study
Updated: 7/7/2015
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study of Escalating Single Doses of MLN3126 in Healthy Subjects
Status: Enrolling
Updated: 7/7/2015
MLN3126 Single Rising Dose Study
Updated: 7/7/2015
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study of Escalating Single Doses of MLN3126 in Healthy Subjects
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
DDI Study With Multiple-dose LX4211 and Single Dose Digoxin
Updated: 7/8/2015
A Phase 1, Single-center, Open-label, Two-period, Single-sequence, Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose LX4211 on the Pharmacokinetics of Single-dose Digoxin (Lanoxin®), a Sensitive P-glycoprotein (P-gp) Substrate, in Healthy Male and Female Subjects
Status: Enrolling
Updated: 7/8/2015
DDI Study With Multiple-dose LX4211 and Single Dose Digoxin
Updated: 7/8/2015
A Phase 1, Single-center, Open-label, Two-period, Single-sequence, Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose LX4211 on the Pharmacokinetics of Single-dose Digoxin (Lanoxin®), a Sensitive P-glycoprotein (P-gp) Substrate, in Healthy Male and Female Subjects
Status: Enrolling
Updated: 7/8/2015
Click here to add this to my saved trials
DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin
Updated: 7/8/2015
A Phase 1, Single-center, Open-label, 2-period, Single-sequence, Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose LX4211 on the Pharmacokinetics of Single-dose Rosuvastatin (Crestor®), a Sensitive Breast Cancer Resistance Protein (BCRP) Substrate, in Healthy Male and Female Subjects
Status: Enrolling
Updated: 7/8/2015
DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin
Updated: 7/8/2015
A Phase 1, Single-center, Open-label, 2-period, Single-sequence, Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose LX4211 on the Pharmacokinetics of Single-dose Rosuvastatin (Crestor®), a Sensitive Breast Cancer Resistance Protein (BCRP) Substrate, in Healthy Male and Female Subjects
Status: Enrolling
Updated: 7/8/2015
Click here to add this to my saved trials
Measurement of Pulse Wave Velocity
Updated: 7/9/2015
Photoplethysmogram Measurement of Pulse Wave Velocity
Status: Enrolling
Updated: 7/9/2015
Measurement of Pulse Wave Velocity
Updated: 7/9/2015
Photoplethysmogram Measurement of Pulse Wave Velocity
Status: Enrolling
Updated: 7/9/2015
Click here to add this to my saved trials
A Phase 1 Study Comparing AVP-786 With AVP-923
Updated: 7/10/2015
A Phase 1, Single-center, Randomized, Double-blind, Double-dummy, 2-way Crossover Study Comparing AVP-786 With AVP-923
Status: Enrolling
Updated: 7/10/2015
A Phase 1 Study Comparing AVP-786 With AVP-923
Updated: 7/10/2015
A Phase 1, Single-center, Randomized, Double-blind, Double-dummy, 2-way Crossover Study Comparing AVP-786 With AVP-923
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Role of Flavanols In Cardiovascular Function in Healthy Aging
Updated: 7/13/2015
Effects of Dietary Flavanols on Cutaneous, Peripheral, and Cerebral Vascular Function in Young and Old Humans
Status: Enrolling
Updated: 7/13/2015
Role of Flavanols In Cardiovascular Function in Healthy Aging
Updated: 7/13/2015
Effects of Dietary Flavanols on Cutaneous, Peripheral, and Cerebral Vascular Function in Young and Old Humans
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
PPV: Pneumococcal Polysaccharide Vaccine in Older Adults
Updated: 7/14/2015
Immunogenicity of Pneumococcal Vaccination and Revaccination in Older Adults
Status: Enrolling
Updated: 7/14/2015
PPV: Pneumococcal Polysaccharide Vaccine in Older Adults
Updated: 7/14/2015
Immunogenicity of Pneumococcal Vaccination and Revaccination in Older Adults
Status: Enrolling
Updated: 7/14/2015
Click here to add this to my saved trials
Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being
Updated: 7/15/2015
Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being
Status: Enrolling
Updated: 7/15/2015
Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being
Updated: 7/15/2015
Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 7/15/2015
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Click here to add this to my saved trials
Genetic Susceptibility TO Ozone-induced Airway Inflammation in Humans
Updated: 7/16/2015
Genetic Susceptibility TO Ozone-induced Bronchial Airway Inflammatory Responses In Humans
Status: Enrolling
Updated: 7/16/2015
Genetic Susceptibility TO Ozone-induced Airway Inflammation in Humans
Updated: 7/16/2015
Genetic Susceptibility TO Ozone-induced Bronchial Airway Inflammatory Responses In Humans
Status: Enrolling
Updated: 7/16/2015
Click here to add this to my saved trials
In-Vivo Bleeding Volume Test for Platelet-Aspirin Interaction
Updated: 7/18/2015
Bleeding Volume Test: A Double-Blind Crossover Randomized Clinical Trial of an In-Vivo On-Line Test for Aspirin Effect and Resistance
Status: Enrolling
Updated: 7/18/2015
In-Vivo Bleeding Volume Test for Platelet-Aspirin Interaction
Updated: 7/18/2015
Bleeding Volume Test: A Double-Blind Crossover Randomized Clinical Trial of an In-Vivo On-Line Test for Aspirin Effect and Resistance
Status: Enrolling
Updated: 7/18/2015
Click here to add this to my saved trials
In-Vivo Bleeding Volume Test for Platelet-Aspirin Interaction
Updated: 7/18/2015
Bleeding Volume Test: A Double-Blind Crossover Randomized Clinical Trial of an In-Vivo On-Line Test for Aspirin Effect and Resistance
Status: Enrolling
Updated: 7/18/2015
In-Vivo Bleeding Volume Test for Platelet-Aspirin Interaction
Updated: 7/18/2015
Bleeding Volume Test: A Double-Blind Crossover Randomized Clinical Trial of an In-Vivo On-Line Test for Aspirin Effect and Resistance
Status: Enrolling
Updated: 7/18/2015
Click here to add this to my saved trials
Immune Memory After Papillomavirus Vaccination
Updated: 7/20/2015
Immune Memory After Papillomavirus Vaccination (IMAP-I) Study . DMID 10-0014
Status: Enrolling
Updated: 7/20/2015
Immune Memory After Papillomavirus Vaccination
Updated: 7/20/2015
Immune Memory After Papillomavirus Vaccination (IMAP-I) Study . DMID 10-0014
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects
Updated: 7/20/2015
A Double-Blind Randomized Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple 1200 mg Dose Intravenous Oritavancin Infusions in Healthy Subjects
Status: Enrolling
Updated: 7/20/2015
Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects
Updated: 7/20/2015
A Double-Blind Randomized Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple 1200 mg Dose Intravenous Oritavancin Infusions in Healthy Subjects
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers
Updated: 7/20/2015
A Phase I, Randomized, Open-Labeled Pharmacokinetic Study of ALZT-OP1 in Normal Healthy Volunteers
Status: Enrolling
Updated: 7/20/2015
Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers
Updated: 7/20/2015
A Phase I, Randomized, Open-Labeled Pharmacokinetic Study of ALZT-OP1 in Normal Healthy Volunteers
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
Fermentation Rate of Infant Formula
Status: Enrolling
Updated: 7/21/2015
Updated: 7/21/2015
Fermentation Rate of Infant Formula
Status: Enrolling
Updated: 7/21/2015
Updated: 7/21/2015
Click here to add this to my saved trials
Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
Updated: 7/21/2015
Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
Status: Enrolling
Updated: 7/21/2015
Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
Updated: 7/21/2015
Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
Status: Enrolling
Updated: 7/21/2015
Click here to add this to my saved trials
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects
Updated: 7/22/2015
A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06372865 In Healthy Adult Subjects
Status: Enrolling
Updated: 7/22/2015
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects
Updated: 7/22/2015
A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06372865 In Healthy Adult Subjects
Status: Enrolling
Updated: 7/22/2015
Click here to add this to my saved trials
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects
Updated: 7/22/2015
A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06372865 In Healthy Adult Subjects
Status: Enrolling
Updated: 7/22/2015
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects
Updated: 7/22/2015
A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06372865 In Healthy Adult Subjects
Status: Enrolling
Updated: 7/22/2015
Click here to add this to my saved trials
Training Effects on Skeletal Muscle Fatty Acid Metabolism
Updated: 7/22/2015
Training Effects on Skeletal Muscle Fatty Acid Metabolism
Status: Enrolling
Updated: 7/22/2015
Training Effects on Skeletal Muscle Fatty Acid Metabolism
Updated: 7/22/2015
Training Effects on Skeletal Muscle Fatty Acid Metabolism
Status: Enrolling
Updated: 7/22/2015
Click here to add this to my saved trials
In Vivo Assessment of Silver Biomaterial Nano-Toxicity
Updated: 7/28/2015
In Vivo Assessment of Silver Biomaterial Nano-Toxicity
Status: Enrolling
Updated: 7/28/2015
In Vivo Assessment of Silver Biomaterial Nano-Toxicity
Updated: 7/28/2015
In Vivo Assessment of Silver Biomaterial Nano-Toxicity
Status: Enrolling
Updated: 7/28/2015
Click here to add this to my saved trials
A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers
Updated: 7/30/2015
A Phase 1, Randomized, Open-label, Parallel-group Study To Evaluate The Pharmacokinetics Of Pf-04856883 (Cvx-096) Following Subcutaneous Administration In Healthy Volunteers
Status: Enrolling
Updated: 7/30/2015
A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers
Updated: 7/30/2015
A Phase 1, Randomized, Open-label, Parallel-group Study To Evaluate The Pharmacokinetics Of Pf-04856883 (Cvx-096) Following Subcutaneous Administration In Healthy Volunteers
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Updated: 7/30/2015
Phase IIA Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Status: Enrolling
Updated: 7/30/2015
Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Updated: 7/30/2015
Phase IIA Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Linking National Guard Veterans With Need to Mental Health Care
Updated: 7/31/2015
Linking National Guard Veterans With Need to Mental Health Care
Status: Enrolling
Updated: 7/31/2015
Linking National Guard Veterans With Need to Mental Health Care
Updated: 7/31/2015
Linking National Guard Veterans With Need to Mental Health Care
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
Updated: 7/31/2015
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
Updated: 7/31/2015
A Phase 1, Multiple-Dose, Open-Label Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
Status: Enrolling
Updated: 7/31/2015
Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
Updated: 7/31/2015
A Phase 1, Multiple-Dose, Open-Label Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
Status: Enrolling
Updated: 7/31/2015
Click here to add this to my saved trials
Role of Exercise in Reversal of Hospitalization-associated Disability in Elderly
Updated: 8/3/2015
Role of Exercise in Reversal of Hospitalization-associated Disability in Elderly
Status: Enrolling
Updated: 8/3/2015
Role of Exercise in Reversal of Hospitalization-associated Disability in Elderly
Updated: 8/3/2015
Role of Exercise in Reversal of Hospitalization-associated Disability in Elderly
Status: Enrolling
Updated: 8/3/2015
Click here to add this to my saved trials
Circadian Brown Adipose Tissue Metabolism
Updated: 8/3/2015
A Pilot Study to Investigate Circadian Variations in Brown Adipose Tissue Metabolism in Healthy Volunteers.
Status: Enrolling
Updated: 8/3/2015
Circadian Brown Adipose Tissue Metabolism
Updated: 8/3/2015
A Pilot Study to Investigate Circadian Variations in Brown Adipose Tissue Metabolism in Healthy Volunteers.
Status: Enrolling
Updated: 8/3/2015
Click here to add this to my saved trials
A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin
Updated: 8/3/2015
A Randomized, Placebo-Controlled, Four-Period Crossover Definitive QT Study Of The Effects of APF530 Exposure, High-Dose IV Granisetron and Moxifloxacin on QTc Prolongation
Status: Enrolling
Updated: 8/3/2015
A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin
Updated: 8/3/2015
A Randomized, Placebo-Controlled, Four-Period Crossover Definitive QT Study Of The Effects of APF530 Exposure, High-Dose IV Granisetron and Moxifloxacin on QTc Prolongation
Status: Enrolling
Updated: 8/3/2015
Click here to add this to my saved trials